Combined liver-kidney transplant: a single centre experience
DOI:
https://doi.org/10.18203/2320-6012.ijrms20260622Keywords:
Living donor transplantation, Liver transplant, Chronic kidney disease, End-stage liver disease, Combined liver-kidney transplantationAbstract
Background: End-stage liver disease (ESLD) often coexists with chronic kidney disease (CKD), creating a need for combined liver-kidney transplantation (CLKT). While widely practiced in the West, Indian experience is limited. Aim was to evaluate the demographic profile, etiologies, peri-operative complications, and short-term in-hospital outcomes of patients undergoing CLKT.
Methods: We retrospectively reviewed adults (>18 years) who underwent CLKT at our centre from January 2019 to February 2025. Records were analysed for demographics, etiology, peri-operative complications and outcomes. CKD was diagnosed by clinical features, imaging, and renal biopsy where indicated; liver disease was confirmed with serology, autoimmune markers, and imaging.
Results: Twenty-three patients underwent CLKT, including 16 males (69.5%). All received live-related donor grafts after regulatory approval. Diabetes (71%) and hypertension (60.8%) were frequent comorbidities. CKD etiology included diabetic kidney disease (60.8%), chronic interstitial nephritis (21.7%), primary hyperoxaluria (8.6%), and chronic glomerulonephritis (8.6%). Liver disease was attributed to non-alcoholic steatohepatitis (NASH) (52.1%), hepatitis B (21.7%), and hepatitis C (17.3%); two hyperoxaluria patients received liver grafts for enzyme deficiency despite structurally normal livers. Postoperative complications included bile leak in 6 patients (23%), bleeding in 1 (4.3%), and prolonged hospitalization in 7 (30.4%). One patient died of sepsis on day 25. At discharge, mean creatinine was 1.0±0.2 mg/dl and bilirubin 1.3±0.7 mg/dl.
Conclusions: CLKT is feasible and safe in the Indian living-donor setting, with results comparable to international reports. Optimal outcomes require careful selection, thorough evaluation, and meticulous perioperative care. Establishing national registries and uniform CLKT guidelines will help standardize practice and ensure equitable allocation.
Metrics
References
Ginès P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;361(13):1279-90. DOI: https://doi.org/10.1056/NEJMra0809139
Sharma P, Welch K, Eikstadt R, Marrero JA, Fontana RJ, Lok AS. Renal outcomes after liver transplantation in patients with renal dysfunction. Transplantation. 2009;15(9):1142-8. DOI: https://doi.org/10.1002/lt.21821
Younossi Z, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84. DOI: https://doi.org/10.1002/hep.28431
Wong RJ, Aguilar M, Cheung R, Ryan BP, Stephen AH, Zobair MY, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver transplantation in the US. Gastroenterology. 2015;148(3):547-55. DOI: https://doi.org/10.1053/j.gastro.2014.11.039
Formica RN, Aeder M, Boyle G, Kucheryavaya A, Stewart D, Hirose R, et al. Simultaneous liver-kidney allocation policy: a proposal to optimize appropriate utilization of scarce resources. Am J Transplant. 2016;16(3):758-66. DOI: https://doi.org/10.1111/ajt.13631
Durand F, Francoz C, Asrani SK. Acute kidney injury after liver transplantation. J Hepatol. 2018;68(4):875-85. DOI: https://doi.org/10.1097/TP.0000000000002305
Rajakannu M, Rammohan A, Narasimhan G. Deceased donor liver transplantation in India: first report of 5-year outcomes. Transplantation. 2024;108(10):2109-16. DOI: https://doi.org/10.1097/TP.0000000000004991
Nadim MK, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, et al. Simultaneous liver–kidney transplantation summit current state and future directions. Transplantation. 2012;12(11):2901-8. DOI: https://doi.org/10.1111/j.1600-6143.2012.04190.x
Levitsky J, Baker T, Ahya SN, Levin ML, Friedewald J, Gallon L, et al. Outcomes following simultaneous liver-kidney transplantation. Am J Transplant. 2019;12(11):2949-57. DOI: https://doi.org/10.1111/j.1600-6143.2012.04182.x
Sharma P, Schaubel DE, Sima CS, Goodrich NP, Merion RM. Reweighted MELD score and simultaneous liver–kidney transplant outcomes. Liver Transpl. 2011;17(3):271-9.
O’Leary JG, Demetris AJ, Friedman LS. The immunologic advantage of combined liver–kidney transplantation. Transplantation. 2014;98(2):127-33.
Fong TL, Bunnapradist S, Jordan SC, Selby RR, Cho YW. Analysis of the United Network for Organ Sharing database: kidney allograft outcome after CLKT. Transplantation. 2003;76(3):348-53. DOI: https://doi.org/10.1097/01.TP.0000071204.03720.BB
Ruiz R, Kunitake H, Wilkinson A, Danovitch GM, Farmer DG, Ghobrial RM, et al. Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg. 2006;141(8):735-41. DOI: https://doi.org/10.1001/archsurg.141.8.735
European Liver Transplant Registry (ELTR). Annual Report. 2022. Available at: https://esot.org/elita/eltr/. Accessed on 17 May 2024.
Egawa H, Teramukai S, Haga H. Long-term outcomes of combined liver-kidney transplantation for polycystic disease. Liver Transpl. 2010;16(8):1028-35.
Brar A, Markmann JF. Outcomes of simultaneous liver–kidney transplantation using donation after circulatory death donors. Transplant Direct. 2020;6(2):e533.
Watson CJE, Kosmoliaptsis V, Pley C. Observations on the ex situ perfusion of livers for transplantation. Lancet. 2018;391(10137):1510-8. DOI: https://doi.org/10.1111/ajt.14687
Schlegel A, Dutkowski P. Role of hypothermic machine perfusion in liver transplantation. Curr Opin Organ Transplant. 2019;24(2):151-8.
Van Rijn R, Schurink IJ, de Vries Y. Delayed kidney implantation during simultaneous liver–kidney transplantation. Transplantation. 2021;105(8):1806-14.
Government of India. Transplantation of Human Organs and Tissues Act, 1994 (Amended 2011). Ministry of Health and Family Welfare, India. 1994. Available at: https://www.notto.mohfw.gov.in/act-end-rules-of-thoa.htm. Accessed on 17 May 2024.